SD 169

CAS No. 1670-87-7

SD 169( —— )

Catalog No. M20928 CAS No. 1670-87-7

SD 169 is a selective and ATP competitive the MAP kinases p38α and p38β inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 27 Get Quote
25MG 46 Get Quote
50MG 72 Get Quote
100MG 110 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SD 169
  • Note
    Research use only, not for human use.
  • Brief Description
    SD 169 is a selective and ATP competitive the MAP kinases p38α and p38β inhibitor.
  • Description
    SD 169 is a selective and ATP competitive the MAP kinases p38α and p38β inhibitor.
  • In Vitro
    SD-169 significantly reduces p38 and HSP60 expression in T cells of the pancreatic beta islets.SD-169 demonstrates 38-fold potency against p38α MAP kinase (IC50=3.2 nM) than p38β MAP kinase (IC50=122 nM).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1670-87-7
  • Formula Weight
    160.17
  • Molecular Formula
    C9H8N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (624.30 mM)
  • SMILES
    NC(=O)c1ccc2[nH]ccc2c1
  • Chemical Name
    1H-Indole-5-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Myers R R Sekiguchi Y Kikuchi S et al. Inhibition of p38 MAP kinase activity enhances axonal regeneration[J]. Experimental Neurology 2003 184(2):0-614.
molnova catalog
related products
  • Nek2-IN-5

    Nek2-IN-5 (NCL00017509) is a potent and selective inhibitor of NIMA-related kinase 2 (Nek2).

  • SC-806

    A potent, orally active p38 MAPK inhibitor with IC50 of 50 nM.

  • p38α inhibitor 4

    p38α inhibitor 4 is a selective MAPK p38α inhibitor, which is used to study diabetes, pain and chronic inflammation.